XML 56 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Acquisitions and Divestitures (Tables)
 6 Months Ended
Jun. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of preliminary estimated fair value
The preliminary estimated fair value of the consideration transferred for IHS Markit was approximately $43.5 billion as of the merger date, which consisted of the following:

(in millions, except for share and per share data)February 28, 2022
Number of shares IHS Markit issued and outstanding* 400,988,207 
Exchange ratio0.2838
Number of S&P Global common stock transferred to IHS Markit stockholders113,800,453 
Closing price per share of S&P Global common stock**$380.89 
Fair value of S&P Global common stock transferred IHS Markit stockholders$43,345 
Fair value of S&P Global replacement equity awards attributable to pre-combination service$191 
Total equity consideration$43,536 

*Excludes 25,219,470 IHS Markit shares held by the Markit Group Holdings Limited Employee Benefit Trust ("EBT"). The shares held by the EBT were converted in the merger into S&P Global shares at the exchange ratio of 0.2838 and will continue to be held by the trustee in the EBT.

**Based on S&P Global's closing stock price on February 25, 2022.
Schedule of preliminary allocation of purchase price recorded The preliminary allocation of purchase price recorded for IHS Markit was as follows:
(in millions)February 28, 2022
Assets acquired
Cash and cash equivalents$310 
Accounts receivable, net968 
Prepaid and other current assets242 
Assets of a business held for sale 1,519 
Property and equipment122 
Right of use assets240 
Goodwill30,986 
Other intangible assets19,162 
Equity investment in unconsolidated subsidiaries1,644 
Other non-current assets86 
Total assets acquired$55,279 
Liabilities assumed
Account payable$174 
Accrued compensation81 
Short-term debt968 
Unearned revenue1,053 
Other current liabilities584 
Liabilities of a business held for sale72 
Long-term debt 4,191 
Lease liabilities - non-current231 
Deferred tax liability - non-current4,333 
Other non-current liabilities56 
Total liabilities assumed$11,743 
Total consideration transferred$43,536 
Schedule of finite-lived intangible assets The following table sets forth preliminary estimated fair values of the components of the identifiable intangible assets acquired and their estimated useful lives:
(in millions)Fair ValueWeighted Average Useful Lives
Customer relationships$14,082 25 years
Trade names and trademarks1,459 14 years
Developed technology1,042 10 years
Databases2,579 12 years
Total Identified Intangible Assets$19,162 21 years
Schedule of expected amortization expense
Expected amortization expense for the Company's intangible assets over the next five years for the years ended December 31 is as follows:

(in millions)20222023202420252026
Amortization expense$926 $1,090 $1,089 $1,053 $1,038 
Schedule of acquisition, pro forma information The pro forma results do not include anticipated synergies or other expected benefits of the acquisition.
Three months ended
June 30		Six months ended
June 30
(in millions)2022202120222021
Revenue$2,970 $3,113 $6,042 $6,135 
Net income$961 $865 $2,491 $1,539 
Schedule of components of assets and liabilities held for sale
The components of assets and liabilities held for sale in the consolidated balance sheet consist of the following:

(in millions)June 30,December 31,
2022
2021 1
Accounts Receivable, net $— $59 
Goodwill— 255 
Other assets— 7 
Assets of businesses held for sale$— $321 
Accounts payable and accrued expenses$— $11 
Unearned revenue— 138 
Liabilities of businesses held for sale$— $149 
1 Assets and liabilities held for sale as of December 31, 2021 relate to CGS and LCD.
The operating profit of our businesses that were disposed of for the periods ended June 30 is as follows:
(in millions)Three MonthsSix Months
2022202120222021
Operating profit 2
$15 $42 $48 $84 
2 The operating profit presented includes the revenue and recurring direct expenses associated with businesses disposed of or held for sale. The three and six months ended June 30, 2022 excludes pre-tax gains related to the sale LCD and a related family of leveraged loan indices of $518 million and $38 million, respectively. The six months ended June 30, 2022 also excludes a pre-tax gain related to the sale of CGS of $1.3 billion. The six months ended June 30, 2021 excludes a pre-tax gain related to the sale of SPIAS of $2 million.